Skip to main content
. 2010 Dec 3;31(12):1604–1610. doi: 10.1038/aps.2010.171

Figure 2.

Figure 2

α-TOS inhibited Akt activation in erbB2-expressing breast cancer cells. MCF7 and MDA-MB-453 cells were treated with α-TOS for varying durations. Total cellular proteins were extracted and used in Western blotting for Akt, p-Akt and β-actin.